HLB Liver Cancer Drug Clinical Trials (HLB 간암 신약 임상)Compare →
Last 30 days: first seen Sep 1 · 2.7h on the board · best rank #5
- Daum 100%
Picked up by Daum only — may be platform-internal dynamics.
Sample — 1 cross-checked sources · 32 snapshots (5-min interval)
Not on the board right now — here's the record of when it was.
«HLB 간암 신약 임상» first surfaced on September 1, 2026, held the board for 2.7h over the last 30 days, peaking at #5. The driver: “New HLB Liver Cancer Drug Improves Survival Regardless of Age… Effectiveness Confirmed in Young Patients as Well”. Currently off the board.
Why it's trending
This is an actual headline, quoted as-is — never summarized or generated.
Related video
HLB 간암 신약 임상
간암 완치 문 열렸다! HLB 신약, 세계 첫 임상 성공
A YouTube video found by searching this keyword.
Related coverage
- [특징주] HLB제약, "간암 신약 임상 결과 긍정적".. '강세' — 글로벌이코노믹
- [특징주] '간암 신약' 임상 긍정적⋯HLB제약 14%대↑ — 아이뉴스24
- HLB, 프리마켓서 7%대 강세…간암 신약 임상결과에 투심 개선[특징주] — v.daum.net
- HLB 간암 신약, 연령 관계없이 생존 개선…젊은 환자도 효과 확인 — ebn.co.kr
·
HLB 간암 신약 임상 first appeared on KoreaTrendBoard on September 1, 2026. It has been observed 32 times since, peaking at rank 5 with a score of 28.0. It was last seen on September 1, 2026.
Rose alongside
Times they appeared on the same board snapshot in the last 7 days. Three or more only — once or twice is chance.
Loading
This chart shows the last 14 days. Pro opens 180 days and lets you export the same data as CSV — one row per day with rank, score and source count. See what opens →
Rose alongside
The number is how many times it appeared on the board at the same moment as this keyword, over the last 7 days.
The full board on 2026-09-01 → · This week · Glossary
Picked up by: DaumReferenced from each site's publicly available rankings. No affiliation or partnership.
Want a heads-up when «HLB 간암 신약 임상» climbs again? It's free.
No signup form — your email is the account. One click to stop.
- 180-day history — the curve, not the moment
- Alerts — pinged within 5 minutes when your keyword moves
- API — ranks and scores straight into your report